Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins
- PMID: 7495246
- DOI: 10.1093/ajcn/62.6.1448S
Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins
Abstract
Epidemiologic data indicate that individuals with low plasma concentrations of carotenoids and antioxidant vitamins and those who smoke cigarettes are at increased risk for age-related macular degeneration (AMD). Laboratory data show that carotenoids and antioxidant vitamins help to protect the retina from oxidative damage initiated in part by absorption of light. Primate retinas accumulate two carotenoids, lutein and zeaxanthin, as the macular pigment, which is most dense at the center of the fovea and declines rapidly in more peripheral regions. The retina also distributes alpha-tocopherol (vitamin E) in a nonuniform spatial pattern. The region of monkey retinas where carotenoids and vitamin E are both low corresponds with a locus where early signs of AMD often appear in humans. The combination of evidence suggests that carotenoids and antioxidant vitamins may help to retard some of the destructive processes in the retina and the retinal pigment epithelium that lead to age-related degeneration of the macula.
Similar articles
-
[The potential role of oxidative stress in the pathogenesis of the age-related macular degeneration (AMD)].Postepy Hig Med Dosw (Online). 2007;61:28-37. Postepy Hig Med Dosw (Online). 2007. PMID: 17245315 Review. Polish.
-
Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group.JAMA. 1994 Nov 9;272(18):1413-20. JAMA. 1994. PMID: 7933422
-
The role of oxidative stress in the pathogenesis of age-related macular degeneration.Surv Ophthalmol. 2000 Sep-Oct;45(2):115-34. doi: 10.1016/s0039-6257(00)00140-5. Surv Ophthalmol. 2000. PMID: 11033038 Review.
-
Intakes of Lutein, Zeaxanthin, and Other Carotenoids and Age-Related Macular Degeneration During 2 Decades of Prospective Follow-up.JAMA Ophthalmol. 2015 Dec;133(12):1415-24. doi: 10.1001/jamaophthalmol.2015.3590. JAMA Ophthalmol. 2015. PMID: 26447482 Free PMC article.
-
Carotenoids and antioxidants in age-related maculopathy italian study: multifocal electroretinogram modifications after 1 year.Ophthalmology. 2008 Feb;115(2):324-333.e2. doi: 10.1016/j.ophtha.2007.05.029. Epub 2007 Aug 22. Ophthalmology. 2008. PMID: 17716735 Clinical Trial.
Cited by
-
Macular pigment density in age-related maculopathy.Graefes Arch Clin Exp Ophthalmol. 2005 Mar;243(3):222-7. doi: 10.1007/s00417-004-0995-7. Epub 2004 Oct 2. Graefes Arch Clin Exp Ophthalmol. 2005. PMID: 15806375
-
Associations of Lipophilic Micronutrients with Physical and Cognitive Fitness in Persons with Mild Cognitive Impairment.Nutrients. 2019 Apr 22;11(4):902. doi: 10.3390/nu11040902. Nutrients. 2019. PMID: 31013604 Free PMC article.
-
Progress and perspectives on the role of RPE cell inflammatory responses in the development of age-related macular degeneration.J Inflamm Res. 2008;1:49-65. doi: 10.2147/jir.s4354. Epub 2008 Dec 2. J Inflamm Res. 2008. PMID: 22096347 Free PMC article.
-
Systemic Effects of Prenatal Carotenoid Supplementation in the Mother and her Child: The Lutein and Zeaxanthin in Pregnancy (L-ZIP) Randomized Trial -Report Number 1.J Nutr. 2023 Aug;153(8):2205-2215. doi: 10.1016/j.tjnut.2023.05.024. Epub 2023 May 27. J Nutr. 2023. PMID: 37247819 Free PMC article. Clinical Trial.
-
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.Arch Ophthalmol. 2001 Oct;119(10):1417-36. doi: 10.1001/archopht.119.10.1417. Arch Ophthalmol. 2001. PMID: 11594942 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical